Home » Topics » BioWorld

BioWorld
RSS

SERAGEN PLANS MORE FUSION TOXIN TRIALS

May 14, 1992

THERATECH BRAVES THE IPO MARKET

May 14, 1992

SYNERGEN-SYNTEX BEGINS ALS TRIALS

May 14, 1992

$180 MILLION SCIOS-NOVA MERGER DEAL

May 14, 1992

DIFFERENT INTERPRETATIONS OF IMNR RESULTS

May 14, 1992

CHUGAI DEAL PROPELS AMGEN

May 14, 1992

TRYOUT FOR EMBREX EGG INOCULATOR

May 14, 1992

PATENT TO COVER CURATIVE TECH PRODUCTS

May 14, 1992

PRICES SAG ACROSS SECTOR

May 13, 1992

ALLELIX, VERAX BIOPROCESSING ALLIANCE

May 13, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...